Gregory Piazza

Underutilization of thromboprophylaxis in patients with heart failure. Dr. Gregory Piazza is interviewed by Dr. George Lundberg.

The acutely decompensated right ventricle: pathways for diagnosis and management.

Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.

Acute pulmonary embolism: part I: epidemiology and diagnosis.

Acute pulmonary embolism: part II: treatment and prophylaxis.

An unusual explanation for episodic dyspnea.

Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent.

Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination.

Venous Thromboembolism Guidebook, fourth edition.

Venous Thromboembolism Guidebook: fifth edition.

Venous thromboembolism guidebook.

Periprocedural management of the chronically anticoagulated patient: critical pathways for bridging therapy.

Heart failure in patients with deep vein thrombosis.

Intracavitary pressure wire and intravascular ultrasound for the evaluation of combined symmetric hypertrophic cardiomyopathy and aortic stenosis in a patient with dyspnea and syncope: treatment with ethanol septal ablation.

Deep vein thrombosis in patients with chronic kidney disease.

Deep-vein thrombosis in the elderly.

Pulmonary embolism in heart failure.

Chest computed tomography in the emergency department for suspected pulmonary embolism: it's time to practice what we preach.

Improving clinical effectiveness in thromboprophylaxis for hospitalized medical patients.

Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients.

Deep vein thrombosis in orthopedic surgery.

Venous thromboembolic events in hospitalised medical patients.

Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond.

Long-term complications of medical patients with hospital-acquired venous thromboembolism.

Medicare's new regulations for deep vein thrombosis as a "never event": wise or worrisome?

Physician alerts to prevent venous thromboembolism.

Thromboangiitis obliterans.

Venous thromboembolism and atherothrombosis: an integrated approach.

Adherence to pharmacological thromboprophylaxis orders in hospitalized patients.

A diagnosis in vein.

Management of submassive pulmonary embolism.

Fibrinolysis for acute pulmonary embolism.

Chronic thromboembolic pulmonary hypertension.

Optimal duration of anticoagulation after venous thromboembolism.

Venous thromboembolism in heart failure: preventable deaths during and after hospitalization.

Hospital budget implications of substituting dabigatran for warfarin in an anticoagulation service.

Dabigatran: a review of clinical and pharmacoeconomic evidence.

Venous thromboembolism in patients with symptomatic atherosclerosis.

Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.

Anticoagulation-associated adverse drug events.

Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.

Patient education program for venous thromboembolism prevention in hospitalized patients.

Cerebral venous thrombosis.

Venous thromboembolism in patients with diabetes mellitus.

Venous thromboembolism in patients with chronic obstructive pulmonary disease.

Submassive pulmonary embolism.

Hospital costs of acute pulmonary embolism.

JAMA patient page. Pulmonary embolism.

Venous thromboembolism in hospitalized patients with active cancer.

Randomized trial of physician alerts for thromboprophylaxis after discharge.

Venous thromboembolism in patients with prior stroke.

Effect of Dabigatran on Referrals to and Switching from Warfarin in Two Academic Anticoagulation Management Services.

Venous thromboembolism and cancer.

Risk assessment to predict arterial and venous events in patients undergoing percutaneous coronary intervention.

Cardiology patient page. Thrombophilia and hypercoagulability.

Thrombophilia testing, recurrent thrombosis, and women's health.

Varicose veins.

Cardiology patient page. Varicose veins.

Cardiology patient page. Warfarin versus novel oral anticoagulants: how to choose?

Is venous thromboembolism a chronic inflammatory disease?

Medication use evaluation: pharmacist rubric for performance improvement.

Fat embolism syndrome.

Regulatory, legislative, and policy updates with anticoagulant use.

Beyond Virchow's Triad: does cardiovascular inflammation explain the recurrent nature of venous thromboembolism?

Mesenteric venous thrombosis.

Performance of Wells Score for Deep Vein Thrombosis in the Inpatient Setting.